Related references
Note: Only part of the references are listed.Systematic Review with Meta-analysis: The Impact of Co-occurring Immune-mediated Inflammatory Diseases on the Disease Course of Inflammatory Bowel Diseases
Mohamed Attauabi et al.
INFLAMMATORY BOWEL DISEASES (2021)
Efficacy of Ustekinumab for Active Perianal Fistulizing Crohn Disease: A Double-Center Cohort Study
Mohamed Attauabi et al.
INFLAMMATORY BOWEL DISEASES (2021)
Ustekinumab for Crohn's Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study
Vince B. C. Biemans et al.
JOURNAL OF CROHNS & COLITIS (2020)
Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAID
Constance Chapuis-Biron et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)
Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn's Disease: The Toronto Consensus
A. Hillary Steinhart et al.
INFLAMMATORY BOWEL DISEASES (2019)
A 10-Year Follow-up Study of the Natural History of Perianal Crohn's Disease in a Danish Population-Based Inception Cohort
Mirabella Zhao et al.
INFLAMMATORY BOWEL DISEASES (2019)
Efficacy of Medical Therapies for Fistulizing Crohn's Disease: Systematic Review and Meta-analysis
Matthew J. Lee et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
FISTULA HEALING IN PIVOTAL STUDIES OF USTEKINUMAB IN CROHN'S DISEASE
Bruce E. Sands et al.
GASTROENTEROLOGY (2017)
Real-Life Data on the Use of Ustekinumab for the Treatment of Fistulas in Patients With Crohn's Disease
Steven Tsistrakis et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
Clinical, endoscopic and radiographic outcomes with ustekinumab in medically-refractory Crohn's disease: real world experience from a multicentre cohort
C. Ma et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn's Disease Refractory to Anti-Tumor Necrosis Factor Agents
Pauline Wils et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease
Krisztina B. Gecse et al.
GUT (2014)
Subcutaneous ustekinumab for the treatment of anti-TNF resistant Crohn's disease-The McGill experience
U. Kopylov et al.
JOURNAL OF CROHNS & COLITIS (2014)
The burden of inflammatory bowel disease in Europe
Johan Burisch et al.
JOURNAL OF CROHNS & COLITIS (2013)
Randomised clinical trial: certolizumab pegol for fistulas in Crohn's disease - subgroup results from a placebo-controlled study
S. Schreiber et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Quality of Life in Perianal Crohn's Disease: What Do Patients Consider Important?
Srihari Mahadev et al.
DISEASES OF THE COLON & RECTUM (2011)
The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn's disease who failed prior infliximab therapy
S. Lichtiger et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Prospective assessment of the effect on quality of life of anti-tumour necrosis factor therapy for perineal Crohn's fistulas
S. C. Ng et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
ANNALS OF INTERNAL MEDICINE (2009)
Effects of Adalimumab Maintenance Therapy on Health-Related Quality of Life of Patients With Crohn's Disease: Patient-Reported Outcomes of the CHARM Trial
Edward V. Loftus et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Predictors of severe Crohn's disease
Catherine Loly et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2008)
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial
Jean-Frederic Colombel et al.
GASTROENTEROLOGY (2007)
Predictors of Crohn's disease
L Beaugerie et al.
GASTROENTEROLOGY (2006)
Infliximab maintenance therapy for fistulizing Crohn's disease
BE Sands et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota
DA Schwartz et al.
GASTROENTEROLOGY (2002)
Share Paper
